Press Releases

Press Releases
3/4/2021 Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd^®
2/26/2021 DIAGNODE-2 results and meta-analysis with Diamyd^® to be presented at diabetes conference
2/22/2021 Diamyd Medical makes an investment in MainlyAI
1/20/2021 Quarterly Report I 20/21
1/14/2021 Positive safety evaluation of Remygen^® in high dose and in combination with Alprazolam gives the go-ahead for the continuation of the trial
1/12/2021 Meta-analysis updated with DIAGNODE-2 results provides further support for a precision medicine approach using Diamyd^®

ORDER

Share This Page

GAD PRODUCTS